5-177513767-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 1P and 1B. PP3BS2_Supporting
The NM_016222.4(DDX41):c.1016G>A(p.Arg339His) variant causes a missense change. The variant allele was found at a frequency of 0.0000539 in 1,613,734 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_016222.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DDX41 | NM_016222.4 | c.1016G>A | p.Arg339His | missense_variant | Exon 10 of 17 | ENST00000330503.12 | NP_057306.2 | |
DDX41 | NM_001321732.2 | c.638G>A | p.Arg213His | missense_variant | Exon 9 of 16 | NP_001308661.1 | ||
DDX41 | NM_001321830.2 | c.638G>A | p.Arg213His | missense_variant | Exon 10 of 17 | NP_001308759.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152130Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251270Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135892
GnomAD4 exome AF: 0.0000534 AC: 78AN: 1461604Hom.: 0 Cov.: 36 AF XY: 0.0000440 AC XY: 32AN XY: 727102
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74320
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in individuals with myelodysplastic syndrome or myeloproliferative neoplasm in published literature (PMID: 37506341, 36542832, 35671390, 31713024, 37199125); This variant is associated with the following publications: (PMID: 34183866, 36542832, 35671390, 36672294, 36036093, 37506341, 27721487, 31713024, 37199125, 37874914, 40040251) -
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 339 of the DDX41 protein (p.Arg339His). This variant is present in population databases (rs774698335, gnomAD 0.02%). This missense change has been observed in individual(s) with myeloproliferative/lymphoproliferative neoplasms (PMID: 31713024, 35671390, 37199125). ClinVar contains an entry for this variant (Variation ID: 434921). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The p.R339H variant (also known as c.1016G>A), located in coding exon 10 of the DDX41 gene, results from a G to A substitution at nucleotide position 1016. The arginine at codon 339 is replaced by histidine, an amino acid with highly similar properties. This alteration has been detected as a presumed germline finding in numerous individuals with a suspected or confirmed myeloid neoplasm (Polprasert C et al. Int J Hematol, 2020 Feb;111:241-246, Li P et al. Blood, 2022 Aug;140:716-755, Badar T et al. Haematologica, 2023 Nov;108:3033-3043, Gutierrez-Rodrigues F et al. Blood, 2023 Apr;141:2100-2113, Cheloor Kovilakam S et al. Blood, 2023 Oct;142:1185-1192, Maierhofer A et al. Blood Adv, 2023 Dec;7:7346-7357). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -
DDX41-related hematologic malignancy predisposition syndrome Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at